TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2020

NSABP B-47/NRG Oncology Phase III Randomized Trial Comparing Adjuvant Chemotherapy With or Without Trastuzumab in High-Risk Invasive Breast Cancer Negative for HER2 by FISH and With IHC 1+ or 2.

Louis Fehrenbacher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.